News & Events

Institute News
Dr Margie Danchin is a Senior Research Fellow in Vaccine and Immunisation Research Tell us about your work I am a general paediatrician and senior research fellow at MCRI. I have worked on vaccine research around clinical trials, vaccine safety and vaccine social science for 10 years. My current focus is around developing new interventions to improve vaccine confidence and uptake. I am passionate about finding ways to help parents choose to immunise their children with confidence and have their questions addressed. Vaccine hesitancy is a global issue and we need effective interventions to sustain confidence in vaccine programs to improve vaccine uptake and reduce vaccine preventable diseases in mothers and children. What are you hoping to achieve through the work that you’re doing/what is your ideal goal? I hope to mandate vaccine conversations with mothers, particularly first time mothers, early and at regular times in pregnancy so that vaccine...
Research News
Rapid genomic testing will soon be available to critically unwell Australian babies and children with suspected genetic conditions, as part of four new national genomic research studies launched by Australian Genomics . From next month, the Acute Care Genomics study will enrol infants and children with suspected genetic conditions from intensive care units across much of the country. The study aims to provide genomic test results in as little as five days to quickly pinpoint the cause of the child’s condition and inform their clinical care. Rapid genomic testing is currently only available at a handful of centres worldwide, and the study will be the first to pioneer a national approach to rapid rare disease diagnosis. The Acute Care Genomics study is co-led by A/Prof Zornitza Stark, A/Prof Marcel Dinger, and Dr. Sebastian Lunke. A/Prof Zornitza Stark is a clinical geneticist at Victorian Clinical Genetics Services (a wholly owned not-for-profit...
Research News
A report released today by the Australian Council of Learned Academies (ACOLA) says that precision medicine has the potential to transform Australia’s health care system. Precision medicine combines knowledge of a person’s unique genetic makeup, protein levels, and their environment to allow accurate disease prevention and treatment tailored to individual needs. To date, the main focus has been in well-supported clinical areas, such as cancer, and ‘rare’ single-gene disorders which are a cause of intellectual and physical disability in children. However, The future of precision medicine in Australia report says that opportunities to improve health outcomes for complex disorders, such as diabetes and cardiovascular disease are equally exciting. “With careful planning, advances in precision medicine and the technologies that support it will offer great value for the health of all Australians. Precision medicine is the personalised medicine of the future,” said the chair of the ACOLA expert working group, Professor...
Research News
Researchers have confirmed positive evidence which could potentially give hope to some parents struggling with colic, or excessive crying in newborns. Babies who cry or fuss a lot and can’t be settled are often described as having ‘colic’. We don’t know what causes colic, but we do know it can be hard to handle. The condition, which affects one in five families, is burdensome and is associated with maternal depression, child abuse such as Shaken Baby Syndrome, and early breastfeeding cessation. Up until now, there has been no effective treatment for colic. A new international study led by the Murdoch Children’s Research Institute (MCRI), in collaboration with 11 other institutions around the world, found the probiotic Lactobacillus reuteri has the potential to provide some reduction in crying in exclusively breastfed babies less than three months old. Researchers found compared to a placebo, the probiotic group was two times more likely...